Eha Advocacy Session 2 - Jan Geissler

EHA Advocacy Session 2 - Jan Geissler

European Hematology Association

Keynote iCMLf Prize 2022: Keynote Jan Geissler

International CML Foundation

EHA Advocacy Session 2 - Guillermo Garcia Manero

European Hematology Association

Patient relevant outcomes and advocacy

Getting the most out of EHA as a CML patient advocate

Getting the most out of EHA25 Virtual. A patient's overview

EHA Advocacy Session 2 - Harpeet Kaur

European Hematology Association

Part 2. Jan Geissler, European Cancer Patient Coalition (ECPC), and Leukämie-Online

The importance of patient advocacy tracks at congresses

VJHemOnc – Video Journal of Hematology & HemOnc

Jan Geissler Explains Differing Perceptions for Living With CML

EHA Advocacy Session 3 - Martin Ingvar

European Hematology Association

Jan Geissler - Patient involvement in clinical research

Myeloma Patients Europe

Patient involvement at ASH 2016 and beyond

VJHemOnc – Video Journal of Hematology & HemOnc

Why European Reference Networks are a game-changer for collaboration in hematology

VJHemOnc – Video Journal of Hematology & HemOnc

The need for patient advocates to attend major congresses such as EBMT

VJHemOnc – Video Journal of Hematology & HemOnc

The aims of the Patvocates Network

VJHemOnc – Video Journal of Hematology & HemOnc

EHA Advocacy Session 3 - Maria Piggin

European Hematology Association

Jan Geissler – ECCO 2019 European Cancer Summit

Touch Medical Media Services

EHA Advocacy Session 1 - Amanda Bok

European Hematology Association

The evolution of patient advocacy

VJHemOnc – Video Journal of Hematology & HemOnc